Trial · NCT00081289
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Neoadjuvant Chemoradiation With Irinotecan | 73 | |
| Overall Study | STARTED | Neoadjuvant Chemoradiation With Oxaliplatin | 73 | |
| Overall Study | Primary Endpoint Population | Neoadjuvant Chemoradiation With Irinotecan | 48 | |
| Overall Study | Primary Endpoint Population | Neoadjuvant Chemoradiation With Oxaliplatin | 48 | |
| Overall Study | General Analysis Population | Neoadjuvant Chemoradiation With Irinotecan | 52 | |
| Overall Study | General Analysis Population | Neoadjuvant Chemoradiation With Oxaliplatin | 52 | |
| Overall Study | Full AE Population | Neoadjuvant Chemoradiation With Irinotecan | 70 | |
| Overall Study | Full AE Population | Neoadjuvant Chemoradiation With Oxaliplatin | 68 | |
| Overall Study | Surgery | Neoadjuvant Chemoradiation With Irinotecan | 47 | |
| Overall Study | Surgery | Neoadjuvant Chemoradiation With Oxaliplatin | 51 | |
| Overall Study | Global Health Status Score at End of CR | Neoadjuvant Chemoradiation With Irinotecan | 34 | |
| Overall Study | Global Health Status Score at End of CR | Neoadjuvant Chemoradiation With Oxaliplatin | 32 | |
| Overall Study | GHS at End of Post-op CT | Neoadjuvant Chemoradiation With Irinotecan | 20 | |
| Overall Study | GHS at End of Post-op CT | Neoadjuvant Chemoradiation With Oxaliplatin | 28 | |
| Overall Study | GHS at Two Years | Neoadjuvant Chemoradiation With Irinotecan | 21 | |
| Overall Study | GHS at Two Years | Neoadjuvant Chemoradiation With Oxaliplatin | 20 | |
| Overall Study | GI Symptom Score at End of CR | Neoadjuvant Chemoradiation With Irinotecan | 34 | |
| Overall Study | GI Symptom Score at End of CR | Neoadjuvant Chemoradiation With Oxaliplatin | 33 | |
| Overall Study | GI Symptom Score at End of Post-op CT | Neoadjuvant Chemoradiation With Irinotecan | 22 | |
| Overall Study | GI Symptom Score at End of Post-op CT | Neoadjuvant Chemoradiation With Oxaliplatin | 27 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00081289/flow